Eitan et al., 2005 - Google Patents
Pilot study prospectively evaluating the use of the measurement of preoperative sonographic endometrial thickness in postmenopausal patients with endometrial …Eitan et al., 2005
- Document ID
- 13245458140230847012
- Author
- Eitan R
- Saenz C
- Venkatraman E
- Hann L
- Bach A
- Gretz E
- Barakat R
- Chi D
- Publication year
- Publication venue
- Menopause
External Links
Snippet
Objective: The value of sonographic evaluation of the endometrial thickness as a screening or a prognostic tool for endometrial cancer remains controversial. The objective of this study was to prospectively evaluate the endometrial thickness in women with known endometrial …
- 230000002357 endometrial 0 title abstract description 55
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57496—Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Timmerman et al. | The pedicle artery sign based on sonography with color Doppler imaging can replace second‐stage tests in women with abnormal vaginal bleeding | |
Peric et al. | The symptomatology of adenomyosis | |
Savelli et al. | Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging | |
Kotdawala et al. | Evaluation of endometrium in peri-menopausal abnormal uterine bleeding | |
Vuento et al. | Screening for endometrial cancer in asymptomatic postmenopausal women with conventional and colour Doppler sonography | |
Rizvi et al. | Histopathological correlation of adenomyosis and leiomyoma in hysterectomy specimens as the cause of abnormal uterine bleeding in women in different age groups in the Kumaon region: A retroprospective study | |
Chen et al. | Comparison of the sensitivity of mammography, ultrasound, magnetic resonance imaging and combinations of these imaging modalities for the detection of small (≤ 2 cm) breast cancer | |
Akin et al. | Imaging of uterine cancer | |
Wiratkapun et al. | Indeterminate or suspicious breast lesions detected initially with MR imaging: value of MRI-directed breast ultrasound | |
Jeong et al. | The usefulness of computed tomographic colonography for evaluation of deep infiltrating endometriosis: comparison with magnetic resonance imaging | |
Cui et al. | Risk of occult uterine sarcoma in presumed uterine fibroids | |
Harris et al. | ACR Appropriateness Criteria® clinically suspected adnexal mass | |
Bhagde et al. | An analytical study of 50 women presenting with an adnexal mass | |
Natarajan et al. | The value of MRI in management of endometrial hyperplasia with atypia | |
Woodfield | The usefulness of ultrasound imaging in gynecologic oncology | |
Kanat-Pektas et al. | The evaluation of endometrial tumors by transvaginal and Doppler ultrasonography | |
Eitan et al. | Pilot study prospectively evaluating the use of the measurement of preoperative sonographic endometrial thickness in postmenopausal patients with endometrial cancer | |
Sanjuán et al. | Role of magnetic resonance imaging and cause of pitfalls in detecting myometrial invasion and cervical involvement in endometrial cancer | |
Marcickiewicz et al. | Accuracy of intraoperative gross visual assessment of myometrial invasion in endometrial cancer | |
Fistonic et al. | Transvaginal sonographic assessment of premalignant and malignant changes in the endometrium in postmenopausal bleeding | |
Zhu et al. | Hysteroscopy and directed biopsy in the diagnosis of endometrial carcinoma | |
Naftalin et al. | Endometrial cancer and ultrasound: why measuring endometrial thickness is sometimes not enough | |
Timmermans et al. | Follow-up of women after a first episode of postmenopausal bleeding and endometrial thickness greater than 4 millimeters | |
Dermawan et al. | Thickened endometrium in postmenopausal women with an initial biopsy of limited, benign, surface endometrium: clinical outcome and subsequent pathologic diagnosis | |
Franconeri et al. | Asymptomatic endometrial thickening of 8 mm or greater on postcontrast computed tomography in postmenopausal women is a predictor of endometrial cancer |